TM
Co2 Hemp extract with over 80 cannabinoids and a multitude of vitamins, minerals, amino acids, omega fatty acids and more, Rattlesnake Oil is the one of the most comprehensive hemp products in the world. It is made with CO2 Hemp Extracts - blend of Raw and Heated cannabinoids (i.e.CBD-A,CBD CBG-A:CBG, CBC) + Steam Distilled Hemp Extract high in terpenes, aldehydes and ketones.
Try one of our signature blends today and begin a healthy journey to a natural of healing!


OUR PRODUCTS DO NOT CONTAIN ANY REAL SNAKE OIL. ITS JUST THE BRAND NAME.

CBD PHILOSOPHY

NATURAL
INGREDIENTS
100%
BALANCE
AND RESTORE

LAB TESTED
​​FOR QUALITY
Nature Makes the Difference
The Perception behind
CBD
Lab Tested
For Quality
WHY HEMP?
The phytocannabinoids, terpene and flavonoid profiles in hemp work perfectly for people and pets. For pets due in part to their small body size, dogs and cats can take advantage of small amounts of CBD, and other cannabinoids found in hemp and can therefore reap the benefits of the most beneficial plant on earth. In addition, they respond to the relatively small or even trace amounts of omega fatty acids, B vitamins and various minerals naturally found in hemp. Perhaps most importantly, when the entire Hemp plant is used, as opposed to individual components of the plant, an increase in health benefits and a decrease in adverse effects are observed. Some of the adverse effects possible in taking CBD only products, particularly those designed for human consumption, are extreme sedation or nausea and they do not offer the desired and most efficacious results that the “entourage effect” provides. The entourage effect results when the cannabis plants’ major phytocannabinoids and other components are permitted to work synergistically with each other, as nature intended.
Products with heavily processed “pure” CBD derived from industrial hemp lack the full spectrum of aromatic terpenes and other cannabinoids found in high-resin drug plants. These compounds interact synergistically with CBD and THC to enhance their therapeutic effects. Scientific research shows that whole plant CBD-rich cannabis oil has a broader range of therapeutic attributes and greater therapeutic efficacy than single-molecule CBD.As far as current federal law goes, any CBD-rich plant that exceeds 0.3 percent THC is considered marijuana and is therefore off limits for growing and extracting. But the Feds are much more lenient when it comes to pharmaceutical THC. Single-molecule THC (sold as “Marinol”) is a Schedule III drug available by prescription in all 50 states, even though it makes one as high as a kite. Schedule III is reserved for therapeutic substances with low abuse potential. Whole plant cannabis, meanwhile, continues to be classified as a dangerous Schedule I drug with no medical value.
Single-molecule compounds are the preferred domain of Big Pharma, which favors patentable isolates over “crude” whole plant synergies. It’s only a matter of time before the Food and Drug Administration gives a thumbs-up to synthetic, single-molecule, pharmaceutical CBD. The FDA, however, is generally not in the business of approving plants as medicines (though there are a few exceptions). The FDA’s single-molecule tilt reflects a cultural and political bias that privileges corporate pharmaceuticals. Single-molecule medicine is the predominant corporate way, the Big Pharma way, but it’s not the only way, and there’s scant evidence that it’s the best way to benefit from cannabis therapeutics.
Cannabidiol (CBD)
is one of the eighty-five Cannabinoids that are present in Cannabis. CBD has been widely studied because it is present in high concentration in Cannabis. The biggest benefit about CBD is that it has a lot of medical benefits and can be quite useful to counteract the THC psychoactivity. Cannabidiol has anti-spasm, anti-anxiety, anti-pain and anti-inflammatory properties.
​
Medical benefits of CBD
CBD can be quite useful in combating cancer cells and tumors. It works wonderfully well to counter depression disorders. It is also useful for suppressing the seizure activity. CBD can also help with neurodegenerative diseases and can help to maintain alertness due to its non-psychoactive properties.
With the growing success of CBD, more and more people are turning to it with the hope of finding a cure of many medical problems where other medicines have failed to make their mark. It is hoped that further researches about CBD will lead to greater medical benefits.
​
What is cannabidiol (CBD)? What is CBD oil?
Cannabidiol (CBD) is a naturally occurring constituent of industrial hemp/cannabis. It is the most abundant non-psychoactive cannabinoid found in cannabis, and is being scientifically investigated for various reasons.
‘CBD oil’ is a cannabis oil that has significant amounts of cannabidiol (CBD) contained within it.
Our CBD oils are derived from industrial hemp, so they could be considered CBD-rich hemp oil, hemp derived CBD oil, or CBD-rich cannabis oil. The form of cannabis we use for our CBD oils is industrial hemp; we do not sell cannabis (Cannabis Indica) in any shape or form.
What is in CBD Oil besides cannabidiol (CBD)?
Our CBD oils contain over 80 different phyto-cannabinoids, most notably cannabidiol (CBD), CBC, CBG, CBN, and probably others yet to be adequately identified. In addition to the cannabinoids present in our industrial hemp oil extracts, there are also many other types of natural molecules and phyto-chemical compounds such as amino acids, carbohydrates, vitamins (including B1, B2, B6, D, & E), fatty acids (including omega 3 & 6), trace minerals (including iron, zinc, calcium, magnesium, & potassium), carotene, chlorophyll, flavanoids, ketones, nitrogenous compounds, alkanes, alcohols, glycosides, pigments, hemp seed oil, water, and terpenes. The most common terpenes in our CBD oils are Myrcene, Beta-caryophyllene, Terpinolene, Linalool, alpha-Pinene, beta-Pinene, Nerolidol og Phytol, trans-alpha-Bergamotene, Limonene/beta-Phellandrene (Co-elution), alpha-Humulene, (E)-beta-Farnesene, and delta-3-Carene.
Why are hemp derived cannabidiol (CBD oil) products so expensive?
Our cannabidiol rich, hemp oil blends (CBD oils) are produced from industrial hemp.
A CO2 oil extraction is performed on the stalks and seeds of mature industrial hemp plants, and the resulting hemp oil is analyzed in a laboratory through an HPLC test. The purified hemp oil is then again analyzed for it’s potency and purity. And then turning this high cbd, hemp oil extract into our final cbd oil blends is another additional process that takes time and resources. These necessary steps to ensure ultimate potency and purity throughout each stage of the process, and the facilities that are required to perform all the steps, all add up to hemp derived cannabidiol (CBD Oil) products being very costly to manufacture.
Is your CBD hemp oil similar to Rick Simpson Hemp Oil?
They are similar, as the hemp oils and potential effects are similar looking and acting. People use the Rick Simpson method with different strains of cannabis buds, so the THC and CBD content of the final oil is always varying greatly, depending on the cannabis the consumers are acquiring. Our product is always made from industrial hemp, and Rick Simpson Hemp Oil from cannabis buds.
How does CBD oil work?
Please research cannabidiol and CBD oil through other trusted resources to educate yourself as to how cannabidiol and hemp may effect the human system.
What’s the difference between Hemp and Cannabis?
Scientifically and genetically, industrial Hemp and cannabis can be the same plant, with a genus and species name of Cannabis Sativa. Industrial Hemp is always a strain of Cannabis sativa, while cannabis can be Cannabis sativa or Cannabis indica. The major difference is how industrial hemp has been bred compared to a high THC form of Cannabis sativa. Industrial hemp is very fibrous, with long strong stalks, and barely has any flowering buds, while a strain of Cannabis sativa will be smaller, bushier, and full of flowering buds.
Is CBD from Hemp as good as CBD from Cannabis Buds?
The short answer is yes. CBD is CBD, whether from Cannabis buds or hemp. Most cannabis has a very low cannabidiol profile, so most of the time hemp would be much more preferable regarding CBD potency because it naturally has such a high amount of it.
Is CBD Legal in the USA?
CBD is currently legal in the USA. Please check if it is legal in your country before ordering
What is the safety of cannabidiol and your Hemp CBD oil? Are there negative side effects?
Cannabidiol, and other phytochemical constituents of cannabis are considered to be generally safe. In hemp’s thousands of years of use there has not been one recorded fatality or major illness contributed to it’s use as far as we are aware, you must always consult your health advisor before consuming any of our products. Very rarely people will complain of a short lasting and mild stomach pain. This usually subsides after 2-3 days of use.
Is a standard hemp seed oil the same as a high CBD content CBD oil?
Absolutely not. Standard hemp oil, which can be found very cheaply at a grocery store, is a much different product than our Hemp CBD oil. Standard hemp oil is produced by cold pressing the seeds, whereas our CBD extract is a supercritical CO2 extraction of the hemp plant itself.
.
Most studies with cannabidiol utilize synthetic, single-molecule CBD produced by biochemical laboratories for research purposes. In contrast, whole plant extractions typically include CBD, CBDa CBG, CBN and more than 400 trace compounds. Many of these compounds interact synergistically to create what scientists refer to as an “entourage effect” that magnifies the therapeutic benefits of the plant’s individual components—so that the medicinal impact of the whole plant is greater than the sum of its parts.
It is important to consider the entourage effect (or lack thereof) when extrapolating data based on independant studies: 100 milligrams of synthetic single-molecule CBD is not equivalent to 100 milligrams of a CBD-rich whole plant cannabis extract.
“Cannabis is inherently polypharmaceutical,” Dr. John McPartland notes, “and synergy arises from interactions between its multiple components.”
-
CBD is the 100% legal and non-psychoactive form of marijuana, and can actually combat unpleasant effects of smoking weed, such as paranoia or over-excitability…
-
CBD acts on completely different receptors and enzymes than THC, resulting in significant effects on anxiety, depression and stress…
-
CBD is completely safe and non-addictive…
-
Pharmaceutical companies can’t patent CBD unless they turn it into a synthetic chemical first…
-
There are shocking demonstrations of the potency of CBD for several serious neurological conditions such as epilepsy, MS and cerebral palsy…
-
CBD can also be used to balance hormones, reduce anxiety, lower inflammation and chronic pain, combat metabolic syndrome, and reduce obesity…
-
It is very difficult for your body to absorb CBD, unless the CBD has been blended with curcuminoids and made bioavailable in a nanoparticle size… …
-
You can legally purchase hemp-based CBD anywhere in America and in most countries of the world…
-
Read more on...
-
HOW TO USE CBD OIL HERE

– The Endocannabinoid System? –
The endogenous cannabinoid system, named after the plant that led to its discovery, is perhaps the most important physiologic system involved in establishing and maintaining human health. Endocannabinoids and their receptors are found throughout the body: in the brain, organs, connective tissues, glands, and immune cells. In each tissue, the cannabinoid system performs different tasks, but the goal is always the same: homeostasis, the maintenance of a stable internal environment despite fluctuations in the external environment. There are two types of cannabinoid receptors found throughout the body (CB1 and CB2), but they are most abundant in the brain and immune system respectively. In a nutshell, your ECS is responsible for making sure your entire body is working optimally.
​
The Endocannabinoid system is involved with many basic functions. It is believed to play a role in memory, mood, sleep, appetite, pain and immune response. It also affects a number of physiological processes including circulation, energy metabolism and organ function. As a result, some scientists believe the overall function of this system is to regulate homeostasis. Homeostasis is a key element in the biology of all living things. It is best described as the ability to maintain stable internal conditions that are necessary for survival. Disease is a result of failing to achieve homeostasis.

Non-psychoactive cannabinoids (including CBD) have been studied extensively for almost three decades see PubMed(US National Library of Medicine National Institutes of Health)for thousands of independent studies, just a few are cited here.
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
British Journal of Pharmacology, Volume 163, Issue 7 – 19 Articles on Cannabinoids
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents
National Cancer Institute – Cannabis and Cannabinoid Research on Animals
Antitumorigenic Effects of Cannabinoids beyond Apoptosis
Beta-caryophyllene is a dietary cannabinoid
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Safety and side effects of cannabidiol, a Cannabis sativa constituent.
Effects of cannabidiol in animal models predictive of antipsychotic activity.
A Study of Infraspecific Flavonoid Variation of Cannabis Sativa L.
Phytocannabinoids beyond the Cannabis plant – do they exist?
A Chemotaxonomic Analysis of Cannabinoid Variation in Cannabis (Cannabaceae)
Cannabinoid and Terprnoid Reference Guide
Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts?
The draft genome and transcriptome of Cannabis sativa
Pharmacokinetics of cannabidiol in dogs
Cannabinoids reduce the progression of Alzheimer’s disease in animals
Cloning and pharmacological characterization of the dog cannabinoid CBâ‚‚ receptor.
Pharmacokinetics of the dimethylheptyl homolog of cannabidiol in dogs.
Comparative metabolism of cannabidiol in dog, rat and man.
CBâ‚‚: therapeutic target-in-waiting.
Phytocannabinoids and endocannabinoids.
Chemistry and Analysis of Phytocannabinoids and Other Cannabis Constituents
Delayed disease progression in ALS mice by treatment with a cannabinoid
Cardiovascular Pharmacology Time-dependent vascular actions of cannabidiol in the rat aorta
Industrial hemp decreases intestinal motility stronger than indian hemp in mice.
Cannabidiol and D9-THC are neuroprotective antioxidants
Neuroprotective antioxidants from marijuana
Cannabis Relieves Lou Gehrigs Symptoms
Prevention of Alzheimer’s Disease Pathology by Cannabinoids
Marijuana Slows Alzheimer’s Decline
Cannabinoids and the skeleton: from marijuana to reversal of bone loss.
Cannabinoids and bone: friend or foe?
Role of cannabinoids in the regulation of bone remodeling.
Role of cannabinoid 2 receptor in the development of bone cancer pain. [Chinese]
A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss.
Cannabis in Palliative Medicine: Improving Care and Reducing Opioid-Related Morbidity
Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro.
The emerging role of the endocannabinoid system in cardiovascular disease.
The endocannabinoid system as a target for the treatment of neurodegenerative disease.
Marijuana Extract Helps Arthritis Pain
Rheumatoid arthritis, Cannabis based medicine eases pain and suppresses disease
Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning.
The endocannabinoid system and energy metabolism.
The emerging role of the endocannabinoid system in endocrine regulation and energy balance.
Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines
Endocannabinoid antagonism: blocking the excess in the treatment of high-risk abdominal obesity.
Cannabinoids in eating disorders and obesity.
[Cannabinoid system and feeding regulation]. [Spanish]
Endogenous cannabinoid system as a modulator of food intake.
The endocannabinoid system and the treatment of obesity.
Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood.
[Endocannabinoid system and energy metabolism: physiology and pathophysiology]. [Italian]
Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases.
The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning?
A Comparison of the Ocular and Central Effects of Δ9-Tetrahydrocannabinol and Cannabigerol.
The endocannabinoid system as a target for the treatment of motor dysfunction.
The endocannabinoid system in Huntington’s disease.
Prospects for cannabinoid therapies in basal ganglia disorders.
Cannabinoids and Parkinson’s disease.
Cannabinoids and neuroprotection in motor-related disorders.
Role of CB2 receptors in neuroprotective effects of cannabinoids.
Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophages.
Cannabidiol inhibits tumour growth in leukaemia and breast cancer in animal studies
Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells.
Antibacterial Cannabinoids from Cannabis sativa: A Structure−Activity Study
[Cannabis and cannabinoids as drugs] Article in Norwegian.
Chemistry, metabolism, and toxicology of cannabis: clinical implications.
Pharmacological actions of cannabinoids.
Cannabinoids against pain. Efficacy and strategies to reduce psychoactivity: a clinical perspective.
Cannabinoid Receptors as Target for Treatment of Osteoporosis: A Tale of Two Therapies
The promise and dilemma of cannabinoid therapy: lessons from animal studies of bone disease
Marijuana in the management of amyotrophic lateral sclerosis
Cannabidiol-caused depression of spinal motoneuron responses in cats.
CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms.
Evidence for novel cannabinoid receptors.
Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
Therapeutic potential of cannabinoids in CNS disease.
The neurobiology and evolution of cannabinoid signalling.
Regulation of nausea and vomiting by cannabinoids.
Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.
The cannabinoid system and pain: towards new drugs?]. [French]
Vascular targets for cannabinoids: animal and human studies
Human skin permeation of Delta8-tetrahydrocannabinol, cannabidiol and cannabinol.
Possible endocannabinoid control of colorectal cancer growth
Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells
The cannabinoids as potential antiepileptics.
Cannabinoids: Defending the Epileptic Brain
Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures.
Marijuana treatments for autoimmune disorders
Cannabidivarin is anticonvulsant in mouse and rat.
Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells
Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 Cannabinoid Receptor1
Cannabinoids, endocannabinoids, and cancer.
Critical appraisal of the potential use of cannabinoids in cancer management
Cannabinoids as potential new therapy for the treatment of gliomas
A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas
Cannabis: discrimination of “internal bliss”?
Cannabis: pharmacology and toxicology in animals and humans.
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
The pharmacology of cannabinoid receptors and their ligands: an overview.
Cannabinoids, immune system and cytokine network.
Targeting cannabinoid agonists for inflammatory and neuropathic pain.
Antineoplastic activity of cannabinoids.
Cannabinoids induce incomplete maturation of cultured human leukemia cells
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease
Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma
Expression and Functional Relevance of Cannabinoid Receptor 1 in Hodgkin Lymphoma
In vivo effects of cannabinoids on macromolecular biosynthesis in Lewis lung carcinomas
Delta-9Tetrahydrocannabinol inhibits growth and metastasis of lung cancer
Marijuana Cuts Lung Cancer Tumor Growth In Half, Study Shows
Cannabinoid receptors as novel targets for the treatment of melanoma
Cannabinoid receptor-1 modulation induces apoptosis of human melanoma cells
Cannabinoids Ameliorate Pain and Reduce Disease Pathology in Cerulein-Induced Acute Pancreatitis
The endocannabinoid signaling system in cancer
Introduction to secondary metabolism in cannabis
Celery, artichokes contain flavonoids that kill human pancreatic cancer cells
Antimicrobial activity of flavonoids
The effects of dietary flavonoids on the regulation of redox inflammatory networks
Cannabis Finds Its Way into Treatment of Crohn’s Disease.
Marijuana Use Patterns Among Patients with Inflammatory Bowel Disease
Anti-inflammatory effects of Cannabinoid 2 Receptor activation in endotoxin-induced uveitis
Cannabidiol: An Overview of Some Pharmacological Aspects
Does Cannabidiol Protect Against Adverse Psychological Effects of THC?
Behavioral effects of cannabinoid agents in animals.
Endocannabinoids in liver disease.
Endocannabinoid chemical biology: a tool for the development of novel therapies.
In vitro metabolism of cannabichromene in seven common laboratory animals.
In vitro metabolism of cannabinol in rat, mouse, rabbit, guinea pig, hamster, gerbil and cat.
In vitro metabolism of cannabigerol in several mammalian species.
A Comparison of the Ocular and Central Effects of Δ9-Tetrahydrocannabinol and Cannabigerol
Comparative in vitro metabolism of the cannabinoids.
How CBD May Cause Cancer Cells to Die in Brain Tumors
Role of 5-HT1 receptors of accumbens shell arenaupon ACPA-induced anxiolytic-like behaviors in rat
Endocannabinoids and the haematological system
Cannabinoids in pancreatic cancer: Correlation with survival and pain
Toward drugs derived from cannabis.
Cannabinoids: Potential Anticancer Agents
Cannabidiol as potential anticancer drug.
Inhibition of tumor angiogenesis by cannabinoids
Anticonvulsant properties of linalool
Limonene & How to Manage Symptoms of Gastroesophageal Reflux Disease
D-Limonene: safety and clinical applications.
Chemoprevention and therapy of cancer by d-limonene.
Cannabinoids for Cancer Treatment: Progress and Promise
Anticonvulsant properties of linalool in glutamate-related seizure models.
Cannabidiol arrests onset of autoimmune diabetes in NOD mice
Natural Products Evaluated in Neuropathic Pain Models – A Systematic Review
Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug.
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action.
Beneficial effects of a Cannabis sativa extract on diabetes induced neuropathy and oxidative stress
Marijuana: The Next Diabetes Drug?
Cannabinoids and the endocannabinoid system in lower urinary tract function and dysfunction.
Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
The cellular processing of the endocannabinoid anandamide and its pharmacological manipulation
Feasibility of Industrial Hemp Production in the United States Pacific Northwest
Industrial Hemp: Global Markets and Prices
Hemp as an Agricultural Commodity